BOLT BIOTHERAPEUTICS
0.6580
08-November-24 12:54:32
15 minutes delayed
Stocks
+0.0067
+1.03%
Today's range
0.6511 - 0.6700
ISIN
N/A
Source
NASDAQ
-
08 Mar 2022 16:30:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Participate in Upcoming February Conferences
02 Feb 2022 08:00:01 By Nasdaq GlobeNewswire
-
06 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Appoints Nicole Onetto, M.D., to Board of Directors
16 Dec 2021 08:00:02 By Nasdaq GlobeNewswire
-
02 Dec 2021 06:00:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Announces Changes to its Board of Directors
19 Nov 2021 08:00:00 By Nasdaq GlobeNewswire
-
12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights
09 Nov 2021 04:05:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at Stifel 2021 Virtual Healthcare Conference
08 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
01 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Participate in Upcoming September Investor Conferences
02 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
-
26 Aug 2021 16:05:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights
12 Aug 2021 16:05:04 By Nasdaq GlobeNewswire
-
04 Jun 2021 09:00:00 By Nasdaq GlobeNewswire
-
Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration
02 Jun 2021 08:00:02 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports First Quarter 2021 Financial Results and Provides Business Highlights
13 May 2021 16:05:00 By Nasdaq GlobeNewswire
-
10 Apr 2021 08:30:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
08 Apr 2021 07:00:00 By Nasdaq GlobeNewswire
-
31 Mar 2021 16:05:00 By Nasdaq GlobeNewswire